Drug details

Dificid (fidaxomicin tablets for oral administration)

type of Macrolides

Dificid (fidaxomicin) is a macrolide antibacterial drug used to reduce the development of drug-resistant bacteria and to treat Clostridium difficile-associated diarrhea (CDAD) in adults over the age of 18. Dificid should only be used to treat infections that are proven or strongly suspected to be caused by Clostridium difficile (also called C. difficile). Dificid is not an effective treatment for systemic infections.

This drug may have the following side effects:

• nausea,
• vomiting,
• diarrhea,
• stomach pain,
• itching
• gas,
• bloating,
• skin rash or

The following drugs are related to Dificid, either as a replacement or used together:

• Principen (ampicillin)
• Benzamycin (erythromycin)
• Bicillin C-R 900/300 (penicillin g benzathine and penicillin g procaine injection)
• Bicillin C-R Tubex (penicillin g benzathine and penicillin g procaine injection)
• Bicillin CR (penicillin g benzathine and penicillin g procaine inj)
• Bicillin L-A Injectable in Tubex (penicillin g benzathine injectable in tubex)
• Cefzil (cefprozil)
• Questran (cholestyramine)
• Cipro (ciprofloxacin)
• Cipro I.V. (ciprofloxacin iv)
• Cipro XR (ciprofloxacin extended-release)
• Rebyota (fecal microbiota rectal, live - jslm suspension, for rectal use)
• Vowst (fecal microbiota spores, live-brpk capsules)
• Levaquin (levofloxacin)
• Sumycin (tetracycline)
• Vancomycin Hydrochloride (vancomycin hydrochloride injection)